Regimens
Filtered By:
- X Remove daSATinib filter daSATinib
- X Remove SORAfenib filter SORAfenib
- X Remove cyclophosphamide filter cyclophosphamide
- X Remove aldesleukin filter aldesleukin
- X Remove blinatumomab filter blinatumomab
- X Remove medroxyprogesterone filter medroxyprogesterone
124 Items
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)
Intent: Curative, Palliative
Intent: Curative, Palliative
Quick Link(s):
Regimen Monograph May 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)
Intent: Curative, Palliative
Intent: Curative, Palliative
Quick Link(s):
Regimen Monograph May 2019
Jan 2018
Cancer Type: Breast
Intent: Neoadjuvant, Adjuvant
Intent: Neoadjuvant, Adjuvant
Quick Link(s):
Regimen Monograph Feb 2018
Cancer Type: Breast
Intent: Curative, Adjuvant
Intent: Curative, Adjuvant
Quick Link(s):
Regimen Monograph 
New
Nov 2019
Cancer Type: Breast
Intent: Neoadjuvant, Adjuvant
Intent: Neoadjuvant, Adjuvant
Quick Link(s):
Regimen Monograph Jan 2019
Cancer Type: Breast
Intent: Curative, Adjuvant
Intent: Curative, Adjuvant
Quick Link(s):
Regimen Monograph 
New
Nov 2019
Cancer Type: Breast
Intent: Neoadjuvant, Adjuvant
Intent: Neoadjuvant, Adjuvant
Quick Link(s):
Regimen Monograph Feb 2018
Cancer Type: Breast
Intent: Neoadjuvant, Adjuvant
Intent: Neoadjuvant, Adjuvant
Feb 2017
Cancer Type: Breast
Intent: Neoadjuvant, Adjuvant
Intent: Neoadjuvant, Adjuvant
May 2016
May 2019
Cancer Type: Skin, Melanoma
Intent: Palliative, Curative
Intent: Palliative, Curative
Quick Link(s):
Regimen Monograph May 2019